# Short-term Testosterone Replacement in Testicular Cancer Survivors

> **NCT03339635** · PHASE2 · COMPLETED · sponsor: **University Medical Center Groningen** · enrollment: 32 (actual)

## Conditions studied

- Testicular Cancer

## Interventions

- **DRUG:** Androgel (Testosterone gel)
- **DRUG:** Placebo gel

## Key facts

- **NCT ID:** NCT03339635
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-21
- **Primary completion:** 2024-06-26
- **Final completion:** 2024-06-26
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2024-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03339635

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03339635, "Short-term Testosterone Replacement in Testicular Cancer Survivors". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03339635. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*